United States of America based
Rubius is developing a new class of drugs, Red-Cell Therapeutics. Rubius is using advanced cellular therapies that harness the unique, inherent properties of red cells and marry them to the creative power of genetic engineering.
TechnologiesStem Cells Startups
No pipelines published yet
No services posted yet